Diagnostic Kit forIHormone yeLuteinizingfluorescence immunochromatographic assay)
Ukusetyenziswa kwe-in vitro diagnostic kuphela
Nceda ufunde le phakheji ifake ngononophelo phambi kokuba uyisebenzise kwaye ulandele ngokungqongqo imiyalelo. Ukuthembeka kweziphumo zovavanyo akunakuqinisekiswa ukuba kukho nakuphi na ukutenxa kwimiyalelo ekweli phakheji.

UKUSETYENZISWA OKUHLOSIWEYO
I-Diagnostic Kit ye-Luteinizing Hormone (i-fluorescence immunochromatographic assay) luvavanyo lwe-fluorescence immunochromatographic yokufumanisa ubungakanani be-Luteinizing Hormone (LH) kwiserum yabantu okanye kwiplasma, esetyenziswa ikakhulu kuvavanyo lwe-pituitary endocrine function. ezinye iindlela. Olu vavanyo lwenzelwe ukusetyenziswa kweengcali zezempilo kuphela.

USHWANKATHELO

I-hormone ye-luteinizing (LH) yi-glycoprotein ene-molecular weight of about 30,000 Dalton, eyenziwa yi-pituitary yangaphambili. Ukuxinwa kwe-LH kuhambelana ngokusondeleyo nokukhutshwa kwama-ovari, kwaye incopho ye-LH iqikelelwa ukuba yi-24 kwiiyure ze-36 ze-ovulation. Ngoko ke, ixabiso eliphakamileyo le-LH linokujongwa ngexesha lokuya esikhathini ukuze kuqinisekiswe ixesha elifanelekileyo lokukhulelwa. Umsebenzi we-endocrine ongaqhelekanga kwi-pituitary gland unokubangela i-LH secretion irregularity.I-concentration ye-LH ingasetyenziselwa ukuvavanya umsebenzi we-pituitary endocrine. I-Diagnostic Kit isekelwe kwi-immunochromatography kwaye inokunika umphumo kwimizuzu eyi-15.

UMGAQO WENKQUBO

I-membrane yesixhobo sovavanyo igqunywe nge-anti-LH ye-antibody kwindawo yovavanyo kunye ne-antibody ye-IgG yebhokhwe kwindawo yolawulo. Iphedi elayibhile iqatywe nge-fluorescence ebhalwe i-anti-LH antibody kunye nomvundla we-IgG kwangaphambili. Xa kuvavanywa isampulu eqinisekileyo, i-antigen ye-LH kwisampulu idibanisa ne-fluorescence ebhalwe i-anti-LH antibody, kwaye yenze umxube wokugonyeka. Phantsi kwesenzo se-immunochromatography, ukuhamba okuntsonkothileyo kwicala lephepha elifunxayo, xa i-complex iphumelele ummandla wovavanyo, idityaniswe ne-anti-LH yokwambathisa i-antibody, yenza into entsha. Inqanaba le-LH linxulunyaniswe ngokufanelekileyo kunye nomqondiso we-fluorescence, kwaye ukuxinwa kwe-LH kwisampulu kunokubonwa ngovavanyo lwe-fluorescence immunoassay.

IIREGENTS KUNYE NEZINTO EZIBONISWAYO

Amacandelo ephakheji ye-25T:

.Ikhadi lovavanyo lwefoyile nganye efakwe kwi-desiccant 25T
.Iisampulu zokuthambisa
.Fakela ipakethe

IZINTO EZIFUNEKAYO KODWA AKUNIKEZWA
Isampulu yokuqokelela isitya,ixesha

UKUQOKELELWA KWEsampuli NOKUGCINWA
1.Iisampulu ezivavanyiweyo zingaba serum, i-heparin anticoagulant plasma okanye i-EDTA anticoagulant plasma.
2.Ngokungqinelana neendlela eziqhelekileyo zokuqokelela isampuli. I-Serum okanye isampuli ye-plasma inokugcinwa efrijini kwi-2-8 ℃ ye-7days kunye ne-cryopreservation engaphantsi kwe-15 ° C kwiinyanga ezi-6.
3.Zonke iisampulu ziphephe imijikelo yokunyibilika komkhenkce.

INKQUBO YOVAVANYO

Inkqubo yovavanyo yesixhobo bona incwadana ye-immunoanalyzer. Inkqubo yovavanyo lwe-reagent ngolu hlobo lulandelayo
I-1.Lay eceleni zonke ii-reagents kunye neesampuli kwiqondo lokushisa.
2.Vula i-Portable Immune Analyzer (WIZ-A101), faka igama lokungena kwi-akhawunti ngokwendlela yokusebenza yesixhobo, kwaye ungenise ujongano lokubona.
3.Skena ikhowudi yokuchaza ukuze uqinisekise into yovavanyo.
4.Khupha ikhadi lovavanyo kwibhegi yefoyile.
5.Faka ikhadi lovavanyo kwi-slot yekhadi, scan ikhowudi ye-QR, kwaye unqume into yovavanyo.
6.Yongeza i-20μL ye-serum okanye isampuli yeplasma kwisampulu ye-diluent, kwaye udibanise kakuhle.
7.Yongeza i-80μL yesisombululo sesampulu kwisampulu kakuhle yekhadi.
8.Cofa iqhosha elithi "standard test", emva kwemizuzu eyi-15, isixhobo siya kubona ngokuzenzekelayo ikhadi lovavanyo, sinokufunda iziphumo kwisikrini sokubonisa isixhobo, kwaye sirekhode / siprinte iziphumo zovavanyo.
9.Jonga kumyalelo we-Portable Immune Analyzer(WIZ-A101).

IZIPHUMO ZOMVAVANYO KUNYE UTOLIKO

.Le datha ingentla lithuba lereferensi elisekwe kwidatha yobhaqo yale khithi, kwaye kucetyiswa ukuba ilabhoratri nganye kufuneka iseke isithuba sesalathiso sokubaluleka kwezonyango olufanelekileyo lwabemi kulo mmandla.
.Uxinzelelo lwe-LH luphezulu kunoluhlu lwereferensi, kwaye utshintsho lwe-physiological okanye impendulo yoxinzelelo kufuneka lungabandakanyi.Ngokuqinisekileyo engaqhelekanga, kufuneka idibanise ukuxilongwa kweempawu zeklinikhi.
.Iziphumo zale ndlela zisebenza kuphela kuluhlu lwereferensi olusekwe yile ndlela, kwaye iziphumo azifani ngokuthe ngqo nezinye iindlela.
.Ezinye izinto zinokubangela iimpazamo kwiziphumo zokubona, kubandakanywa nezizathu zobugcisa, iimpazamo zokusebenza kunye nezinye izinto zesampulu.

UKUGCINWA NOZINZI
1.Ikhithi ziinyanga ezili-18 zobomi beshelufa ukusukela kumhla wokwenziwa. Gcina iikhithi ezingasetyenziswanga kwi-2-30°C. MUSA UKUMKHENZA. Musa ukusebenzisa ngaphaya komhla wokuphelelwa.
2.Musa ukuvula isingxobo esitywiniweyo de ube ulungele ukwenza uvavanyo, kwaye uvavanyo lokusetyenziswa olunye lucetyiswa ukuba lusetyenziswe phantsi kwendawo efunekayo (iqondo lobushushu 2-35℃, ukufuma 40-90%) ngaphakathi kwemizuzu engama-60 ngokukhawuleza. kangangoko kunokwenzeka.
I-3.I-diluent yesampuli isetyenziswa ngokukhawuleza emva kokuvulwa.

IZILUMKISO NEMIGAQO
.Ikhithi kufuneka itywinwe kwaye ikhuselwe kumswakama.
.Yonke imizekelo emihle iya kuqinisekiswa ngezinye iindlela.
.Yonke imizekelo iya kuphathwa njengongcoliseko olunokubakho.
.USUKU sebenzisa i-reagent ephelelwe lixesha.
. AKUKHO ukutshintshiselana kwee-reagents phakathi kweekhithi ezineenombolo ezahlukeneyo.
.USUKU phinda usebenzise amakhadi ovavanyo kunye naziphi na izincedisi ezilahlwayo.
.I-Misoperation, isampuli eninzi okanye encinci inokukhokelela ekuphambukeni kweziphumo.

LUKUXELELA
.Njengalo naluphi na uvavanyo olusebenzisa izilwa-buhlungu zegundane, kunokwenzeka ukuba kukho ukuphazanyiswa yi-anti-mouse antibodies (HAMA) kwi-specimen. Iisampulu ezisuka kwizigulane ezifumene amalungiselelo ee-antibodies ze-monoclonal zokuxilongwa okanye unyango zingaquka i-HAMA. Imizekelo enjalo inokubangela ubuxoki okanye iziphumo ezingalunganga.
.Esi siphumo sovavanyo kuphela kwireferensi yeklinikhi, akufanele sisebenze njengesiseko kuphela sokuxilongwa kweklinikhi kunye nonyango, izigulane zolawulo lwezonyango kufuneka ziqwalaselwe ngokubanzi kunye neempawu zayo, imbali yonyango, ezinye iimviwo zebhubhoratri, impendulo yonyango, i-epidemiology kunye nolunye ulwazi. .
.Le reagent isetyenziselwa kuphela iimvavanyo ze-serum kunye ne-plasma. Isenokungafumani ziphumo zichanekileyo xa isetyenziselwa ezinye iisampulu ezinje ngamathe nomchamo, njl.

IIMPAWU ZOKUSEBENZA

IZIQINISEKISO
1.Hansen JH, et al.HAMA Ukuphazamiseka kunye ne-Murine Monoclonal Antibody-Based Immunoassays [J] .J ye-Clin Immunoassay, 1993, 16: 294-299.
2.Levinson SS.Ubume be-Heterophilic Antibodies kunye nendima kwi-Immunoassay Interference[J].J ye-Clin Immunoassay,1992,15:108-114.

Isitshixo kwiisimboli ezisetyenzisiweyo:

	In Vitro Diagnostic Medical Isixhobo
	Umenzi
	Gcina kwi-2-30 ℃
	Umhla WOKUPHELELWA
	Musa Ukuphinda Usebenzise
	ISILUMKO
	Qhagamshelana neMiyalelo yokuSetyenziswa

Xiamen Wiz Biotech CO.,LTD
Idilesi: 3-4 Floor,NO.16 Building,Bio-medical Workshop,2030 Wengjiao West Road,Haicang District,361026,Xiamen,China
Umnxeba: + 86-592-6808278
Ifeksi: + 86-592-6808279